Search results
Regeneron (REGN) Q4 Earnings & Sales Beat, Eylea Sales Decline
Zacks via Yahoo Finance· 1 year agoRegeneron Pharmaceuticals, Inc. REGN delivered better-than-expected fourth-quarter 2022 results even...
Regeneron (REGN) Down 2.3% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 2 years agoA month has gone by since the last earnings report for Regeneron (REGN). Shares have lost about 2.3%...
Regeneron expands in gene editing with Mammoth deal
BioPharma Dive via Yahoo Finance· 1 month agoDive Brief: Regeneron Pharmaceuticals is upping its investment in genetic medicine, announcing Thursday a $100 million deal with CRISPR drug developer...
This Recent FDA Approval Could Give Regeneron's Top Line a Big Boost
Motley Fool· 8 months agoRegeneron Pharmaceuticals (NASDAQ: REGN) has made for a fantastic growth story over the years. From...
Why Biden's bout with COVID-19 is likely to be easier than Trump's
LA Times via Yahoo News· 2 years agoPresident Biden walks on the South Lawn of the White House after stepping off Marine One on...
Covid-19 has changed and so has our immunity. Here’s how to think about risk from the virus now
CNN via Yahoo News· 9 months agoCovid-19 was never just another cold. We knew it was going to stick around and keep changing to try...
Why Regeneron Pharmaceuticals Shares Are Trading Lower Today
Benzinga via Yahoo Finance· 1 year agoRegeneron Pharmaceuticals Inc (NASDAQ: REGN) earned adjusted EPS of $10.09, down 12% Y/Y, beating...
Regeneron allays competition fears for 'gold standard' eye drug, shares rise
Reuters via Yahoo News· 2 years ago(Reuters) -Regeneron Pharmaceuticals said on Wednesday it expects demand for blockbuster eye drug...
Regeneron (REGN) Outperforms YTD: What's in Store for 2023?
Zacks via Yahoo Finance· 2 years agoRegeneron Pharmaceuticals, Inc. REGN is having a good run, with shares gaining 16.4% in the year so...
Regeneron Pharmaceuticals Inc (REGN) Reports Modest Revenue Growth Amidst Strong Dupixent Sales
GuruFocus.com via Yahoo Finance· 4 months agoRevenue Growth: Full year 2023 revenues increased by 8% to $13.12 billion, with a 14% rise excluding...